Abstract
Eosinophilic colitis is a rare inflammatory bowel disease of unclear origin. It occurs mainly in neonates and in young adults. To date, only one case of treatment in eosinophilic colitis with omalizumab has been described. Here, we present 3 patient cases with eosinophilic colitis which have been treated with omalizumab. Omalizumab is indicated for the treatment of severe allergic asthma and chronic spontaneous urticaria.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
